HOME JOIN TOOLS SITEMAP CONTACT
February 10, 2016, 9:05 am
Home
Chinese group offers $1.2 billion for Opera browser
February 10th, 2016
A Chinese consortium of internet gaming and advertising firms has offered to buy the Opera browser for $1.2 billion.





DraftKings' value has tumbled by 60%, Fox says
February 10th, 2016
Fox, which invested $160 million in DraftKings last summer, now has reduced the value of that holding on its books by 60%.





Janet Yellen: Market turmoil and dollar could hurt economy
February 10th, 2016
Fed Chair Janet Yellen's testimony highlighted concerns about the most recent volatility in global markets as well as the economy's gains.



Why investors are freaking out over European banks (again)
February 10th, 2016
Worries about the global economy and crashing oil prices are causing investors to question the health of big banks -- especially ones in Europe.



Stocks: 6 things to know before the open
February 10th, 2016
Here's what you need to know about the markets before you start your business day.




Stocks stay turbulent as oil dives below $28
February 10th, 2016
The Dow, S&P 500 and Nasdaq remained volatile following steep losses overseas and another plunge in oil prices below $28 a barrel.




America has near record 5.6 million job openings
February 10th, 2016
Read full story for latest details.




No Super Bowl bump for Fitbit. Stock at all-time low
February 10th, 2016


Featured Stories

lick here to visit Yahoo Finance
Fed's Yellen cites global risks but says U.S. should motor through
Sick Investment Tools, Copyright © 2009-2011, Sick Investment Tools LLC. All rights reserved. The content of this site may not be redistributed without the express written consent of Sick Investment Tools. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Sick Investment Tools as well as a link to www.sickinvestmenttools.com. Your privacy is important to usówe will never rent or sell your e-mail or personal information. Please read our Privacy Policy.

No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Sick Investment Tools does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Sick Investment Tools may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.